Photo from wikipedia
To evaluate the efficacy of docetaxel and androgen receptor axis‐targeted (ARAT) agents in patients with castration‐resistant prostate cancer (CRPC) with intraductal carcinoma of the prostate (IDC‐P) using a propensity score‐matched… Click to show full abstract
To evaluate the efficacy of docetaxel and androgen receptor axis‐targeted (ARAT) agents in patients with castration‐resistant prostate cancer (CRPC) with intraductal carcinoma of the prostate (IDC‐P) using a propensity score‐matched analysis.
Keywords:
prostate;
docetaxel androgen;
receptor axis;
axis targeted;
agents patients;
androgen receptor
Journal Title: BJU International
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: BJU International
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!